ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Commentary on Quantitative Comorbidity Risk Assessment of Dementia in Taiwan

Jui-Hsiu Tsai1,2, Chun-Hung Richard Lin3*, Jain-Shing Liu4 and Shih-Pin Chen3
1Calo Psychiatric Center, Pingtung, Taiwan
2Program in Environmental and Occupation Medicine, (Taiwan) National Health Research Institutes and Kaohsiung Medical University, Kaohsiung, Taiwan
3Department of Computer Science and Engineering, National Sun Yat-Sen University, Kaohsiung, Taiwan
4Department of Computer Science and Information Engineering, Providence University, Taichung, Taiwan
*Corresponding Author: Chun-Hung Richard Lin, Department of Computer Science and Engineering, National Sun Yat-Sen University, No. 70 Lien-hai Rd, Kaohsiung 804, Taiwan, Tel: +886 5252000, Email: lin@cse.nysu.edu.tw

Received: 27-Jul-2018 / Accepted Date: 08-Aug-2018 / Published Date: 15-Aug-2018 DOI: 10.4172/2161-0460.1000445

Machine Learning Algorithms in Medical Big Data [1,2]

Machine learning algorithms apply statistical technologies to obtain a clearer understanding of complex big data [3,4]. In order to apply machine learning algorithms to medical research, big enough related dataset must be collected first. For a massive amount of data to be of value for further applications or decision making, it must be analyzed to extract insights. Data analytics entails extracting information from dataset by machine learning algorithms. (Figure 1) illustrates the procedure of moving from big data collection to insight to decision (or prediction). Researchers in the field of machine learning believe that there exists a process that explains the data we observe, for example, the comorbidities of dementia. Although the details of the process underlying the generation of data is unknown, at least it must not be completely random. That is, there exist certain patterns in the data. Machine learning technologies may not be able to identify the process completely, but it can construct a good and useful approximation. This approximation may not explain everything, but may still be able to account for some part of the data. Althrough identifying the complete process may not be possible, certain patterns or regularities can still be detected.

Figure 1: Big data collection and predictive analytics moving from data to insight to decision.

This is the niche of machine learning. Such patterns may help us understand the process, or we can use those patterns to make predictions: If the future, at least the near future, will not be greatly different from the past in which a massive sample data was collected, then predictions can also be expected to be accurate. Machine learning algorithms are applied in many domains, but different performance metrics are appropriate for different domains. For example, the Receiver Operating Characteristic (ROC) curve area is preferred in medicine. Other extensively used metrics include accuracy, F-score, Lift, average precision, precision/recall break-even point, squared error, and crossentropy. The performance metrics illustrate different trade-offs in the predictions made by a classifier. Therefore, a learning algorithm may perform well on one metric, but perform sub-optimally on other metrics. Accordingly, algorithms are evaluated using a broad set of performance metrics.

Evaluating Quantitative Comorbidity Risks of Senile Dementia in Taiwan

Dementia is one of the most dependent and disabling illnesses among older people [5,6]. Many potential risk factors for dementia such as socio-demographic status, lifestyle, medications, genetic characteristics, environmental phenomena, and comorbidities, have been identified [7-9]. Comorbidities can be easily checked out and treated by physicians. Elderly people with dementia have more than 1 chronic comorbidity [6,10,11]. However, the reports on evaluating quantitative comorbidity risks of dementia remain ignored. Lin et al. [6] first introduced a machine learning algorithm to assess quantitative comorbidity risks of dementia in Taiwan. (Figure 2) presents all adjusted Odds Ratios (ORs) observed for people with 1 to 6 comorbidities of dementia. In brief, the quantitative effects of 2 to 6 comorbidities and age difference on dementia slowly raised and the corresponding ORs were less than additive [6]. Notably, the highest adjusted ORs of dementia with 1 to 6 comorbidities were 4.938 (for depression), 6.726 (for depression and vascular disease), 6.841 (for depression, head injury, and vascular disease), 8.619 (for depression, head injury, vascular disease, and hearing loss), 8.767 (for depression, head injury, vascular disease, hearing loss, and diabetes mellitus), and 5.954 (for depression and the 5 other comorbidities), respectively. The data reveal that depression is one of significant comorbidity risk factors for dementia. Several hypotheses have been presented to address the relationship between depression and dementia [6,9,12,13]. First, depression is an early prodromal symptom/sign of dementia. A clinical trial by Muliyala et al. [12] illustrated that the prevalence of dementia reduced by 10% over 7 years when the cases with depression were treated [12]. Second, depression is an independent risk factor for dementia. Even if depression was controlled at early stages, it could not eliminate an attack of dementia or may only decline the incidence of disability [9]. A systematic review [13] demonstrated that people with no history of depression have a lower risk of subsequent dementia in later life than do those with depression. Moreover, depression and dementia may share a common etiology in the brain. Patients with dementia experience the negative biological effects which may be associated with the etiology of depression, such as inflammation, increased blood brain barrier permeability, white matter damage, and increased cortisol concentrations [9].

Figure 2: All odds ratios observed for patients with 1 to 6 comorbidities of dementia after adjustment for age, sex, urban residence, and income level. Red dot involved the comorbidity with depression; black dot did not involve depression.

Summary

In clinical practice, machine learning algorithms provide insights for making predictions and decisions in the treatment of dementia. Future studies on dementia should involve additional heterogeneous variables, including socio-demographic status (e.g., family history, and education), lifestyle factors (e.g., unhealthy diet, drinking and smoking habits, and physical inactivity), medications, environmental phenomena, and genetic characteristics (e.g. Apolipoprotein (APOE)). In addition, this article suggests primary care physicians for early prevention of depression in dementia development.

Acknowledgement

This research was funded by the National Sun Yat-sen University and Kaohsiung Medical University Joint Research Project (NSYSU-KMU 106-I008).

References

  1. Caruana R, Karampatziakis N, Yessenalina A (2008) An empirical evaluation of supervised learning in high dimensions. Proceedings of the 25th International Conference on Machine Learning.
  2. Caruana R, Niculescu-Mizil A (2006) An empirical comparison of supervised learning algorithms. Proceedings of the 23rd International Conference on Machine Learning.
  3. Deo RC (2015) Machine Learning in Medicine. Circulation 132: 1920-1930.
  4. Iniesta R, Stahl D, McGuffin P (2016) Machine learning, statistical learning and the future of biological research in psychiatry. Psychol Med 46: 2455-2465.
  5. Wen YH, Wu SS, Lin CH, Tsai JH, Yang P, et al. (2016) A bayesian approach to identifying new risk factors for dementia: A nationwide population-based study. Medicine (Baltimore) 95: e3658.
  6. Lin CR, Tsai JH, Wu SS, Chang YP, Wen YH, et al. (2018) Quantitative comorbidity risk assessment of dementia in Taiwan: A population-based cohort study. Medicine (Baltimore) 97: e0298.
  7. Chen JH, Lin KP, Chen YC (2009) Risk factors for dementia. J Formos Med Assoc 108: 754-764.
  8. Reitz C, Mayeux R (2014) Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 88: 640-651.
  9. Ritchie K, Carrière I, Ritchie CW, Berr C, Artero S, et al. (2010) Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ 341: c3885.
  10. Fulton MM, Allen ER (2005) Polypharmacy in the elderly: A literature review. J Am Acad Nurse Pract 17: 123-132.
  11. Jörgensen T, Johansson S, Kennerfalk A, Wallander MA, Svärdsudd K (2001) Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 35: 1004-1009.
  12. Muliyala KP, Varghese M (2010) The complex relationship between depression and dementia. Ann Indian Acad Neurol 13: S69-S73.
  13. Wang J, Wu X, Lai W, Long E, Zhang X, et al. (2017) Prevalence of depression and depressive symptoms among outpatients: A systematic review and meta-analysis. BMJ Open 7: e017173.

Citation: Sai JT, Lin CR, Liu J, Chen J (2018) Commentary on Quantitative Comorbidity Risk Assessment of Dementia in Taiwan. J Alzheimers Dis Parkinsonism 8: 445. DOI: 10.4172/2161-0460.1000445

Copyright: © 2018 Sai JT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

https://bahigox.fun/ https://bahisjet.fun/ https://bahsegel.fun/ https://betboo.fun/ https://betdoksan.xyz/ https://betebetgiris.xyz/ https://betexper.fun/ https://betgram.fun/ https://betkanyon.fun/ https://betkolik.fun/
Top